Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting
- PMID: 9342889
- PMCID: PMC2486968
Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting
Abstract
A Joint WHO/National Institute of Allergy and Infectious Diseases (NIAID) meeting on the current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development was held in Bethesda, MD, from 30 September to 1 October 1996. The meeting summarized the worldwide impact of RSV and PIV3; presented the current status of development of RSV and PIV3 vaccines; and examined the applications of recombinant DNA technology to the development and characterization of vaccines and to the understanding of viral pathogenesis.
Similar articles
-
Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.Virology. 1999 Jul 20;260(1):125-35. doi: 10.1006/viro.1999.9802. Virology. 1999. PMID: 10405364
-
Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children.Pediatr Infect Dis J. 2012 Feb;31(2):109-14. doi: 10.1097/INF.0b013e31823386f1. Pediatr Infect Dis J. 2012. PMID: 21926667 Clinical Trial.
-
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.J Infect Dis. 2004 Dec 15;190(12):2096-103. doi: 10.1086/425981. Epub 2004 Nov 8. J Infect Dis. 2004. PMID: 15551207 Clinical Trial.
-
Current approaches to the development of vaccines effective against parainfluenza viruses.Bull World Health Organ. 1988;66(3):391-7. Bull World Health Organ. 1988. PMID: 2844427 Free PMC article. Review.
-
Current status of vaccines for parainfluenza virus infections.Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S123-5. doi: 10.1097/INF.0b013e318168b76f. Pediatr Infect Dis J. 2008. PMID: 18820572 Review.
Cited by
-
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.J Infect. 2004 Oct;49(3):179-209. doi: 10.1016/j.jinf.2004.05.018. J Infect. 2004. PMID: 15337336 Free PMC article. Review.
-
Respiratory syncytial virus genetic and antigenic diversity.Clin Microbiol Rev. 2000 Jan;13(1):1-15, table of contents. doi: 10.1128/CMR.13.1.1. Clin Microbiol Rev. 2000. PMID: 10627488 Free PMC article. Review.
-
Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.J Virol. 1999 Apr;73(4):2956-62. doi: 10.1128/JVI.73.4.2956-2962.1999. J Virol. 1999. PMID: 10074145 Free PMC article.
-
Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997.Eur J Epidemiol. 1999 May;15(5):475-84. doi: 10.1023/a:1007511018330. Eur J Epidemiol. 1999. PMID: 10442474
MeSH terms
Substances
LinkOut - more resources
Full Text Sources